Fatty plaque builds up in artery walls even when LDL cholesterol is below the normal limit of 100 mg/dL.
From We Are Witnessing The End of Heart Attacks · videoSee the scientific wording
Atherosclerotic plaque develops in arterial walls even when LDL cholesterol is within the normal range (below 100 mg/dL); the absolute risk or proportion of individuals who develop plaque under this condition is not reported.
Not tested yet
No study measured the main part of this claim. No part of this claim has been tested yet.
Not tested yet
No study measured the main part of this claim. No part of this claim has been tested yet.
Parts of this claim
Atherosclerotic plaque develops in arterial walls even when LDL cholesterol is within the normal range (below 100 mg/dL).
Not testedNo studies
Evidence is judged against each part on its own, so a study that tests one part never counts as a verdict on the whole claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed
Related videos
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Fatty plaque builds up in artery walls even when LDL cholesterol is below the normal limit of 100 mg/dL.
Evidence from Studies
Last searched 4d ago
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of Imaging-Detected Atherosclerotic Plaque in Adults with LDL Cholesterol Below 100 mg/dL
Systematic search of cohort and cross-sectional imaging studies (e.g., carotid ultrasound, coronary CT angiography, intravascular ultrasound) that report plaque presence or progression in adults with LDL <100 mg/dL; random-effects meta-analysis of absolute prevalence/incidence, with subgroup analysis by age, sex, and comorbidities.
Randomized Trial of LDL Targets and Atherosclerotic Plaque Progression in Adults with Normal-Range LDL
Randomized, double-blind (or open-label with blinded endpoint) trial in adults with LDL <100 mg/dL at baseline; intervention: intensive LDL-lowering to <70 mg/dL versus maintaining <100 mg/dL; comparator: usual care; outcomes: serial intravascular ultrasound or coronary CT angiography plaque burden over 24 months.
Prospective Cohort Study of Incident Atherosclerotic Plaque in Adults with LDL Below 100 mg/dL
Prospective cohort of adults with LDL <100 mg/dL and no baseline plaque; serial imaging (carotid ultrasound or coronary CT angiography) every 12–24 months for 5 years; outcome: new plaque detection or plaque progression; adjust for age, sex, smoking, blood pressure, diabetes.
Cross-Sectional Imaging Study of Plaque Prevalence in Adults with LDL Below 100 mg/dL
Cross-sectional study of a representative sample of adults with LDL <100 mg/dL; imaging (e.g., carotid ultrasound or coronary calcium score) to detect plaque; measure prevalence and compare with matched adults with higher LDL.
Animal Model of Atherosclerotic Plaque Development with Normal-Range LDL Cholesterol
ApoE-/- or LDLR-/- mice fed a diet that maintains LDL cholesterol below the human-equivalent of 100 mg/dL; serial aortic imaging or histology at 12–24 weeks to quantify plaque area; comparator: animals with higher LDL.